Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition | Pew Research Center

February 22, 2024

How Americans View Weight-Loss Drugs and Their Potential Impact on Obesity in the U.S.

Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition

Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition

Download

Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition

← Prev Page

12 3 4 5 6

Infographic Gallery

How Americans View Weight-Loss Drugs and Their Potential Impact on Obesity in the U.S.
Americans more likely to view Ozempic, similar drugs as good weight-loss options for people with obesity than for people without a weight-related condition
Modest expectations for the impact Ozempic and other similar drugs will have on obesity in America
65% of Americans say willpower alone is not enough for most people to lose weight and keep it off
Views on weight loss and willpower by respondents’ description of their own weight
Diet and exercise top public’s list of factors affecting a person’s weight; many also cite stress and anxiety
Women are more likely than men to say stress and anxiety affects a person’s weight a great deal